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Abstract
Background: Applying evidence is one of the most challenging steps of evidence-based clinical practice. Healthcare
professionals have difficulty interpreting evidence and translating it to patients. Decision boxes are summaries of the
most important benefits and harms of diagnostic, therapeutic, and preventive health interventions provided to
healthcare professionals before they meet the patient. Our hypothesis is that Decision boxes will prepare clinicians to
help patients make informed value-based decisions. By acting as primers, the boxes will enhance the application of
evidence-based practices and increase shared decision making during the clinical encounter. The objectives of this
study are to provide a framework for developing Decision boxes and testing their value to users.
Methods/Design: We will begin by developing Decision box prototypes for 10 clinical conditions or topics based on
a review of the research on risk communication. We will present two prototypes to purposeful samples of 16 family
physicians distributed in two focus groups, and 32 patients distributed in four focus groups. We will use the User
Experience Model framework to explore users’ perceptions of the content and format of each prototype. All
discussions will be transcribed, and two researchers will independently perform a hybrid deductive/inductive
thematic qualitative analysis of the data. The coding scheme will be developed a priori from the User Experience
Model’s seven themes (valuable, usable, credible, useful, desirable, accessible and findable), and will include new
themes suggested by the data (inductive analysis). Key findings will be triangulated using additional publications on
the design of tools to improve risk communication. All 10 Decision boxes will be modified in light of our findings.
Discussion: This study will produce a robust framework for developing and testing Decision boxes that will serve
healthcare professionals and patients alike. It is the first step in the development and implementation of a new
tool that should facilitate decision making in clinical practice.
Background
Evidence-based medicine refers to the conscientious,
explicit, and judicious use of current best evidence when
making decisions about health care [1]. Practicing evi-
dence-based medicine means integrating a practitioner’s
personal clinical expertise with the best clinical evidence
available from scientific research [1]. Applying evidence
in clinical practice is one of the most challenging
aspects of evidence-based practice, in part because phy-
sicians find it difficult to interpret evidence [2]. More
specifically, physicians do not always correctly estimate
the benefits and harms of the interventions they com-
monly recommend [3]. Physicians are also unclear about
how best to discuss the benefits and harms of treatment
with patients [4], this despite evidence that how health
professionals present clinical information influences
patients’ perception of risks-and ultimately, decisions
about treatment [5,6].
It is clear, then, that strategies to help physicians easily
access and understand evidence of the benefits and harms
of healthcare interventions are needed if physicians are to
better communicate this knowledge to their patients.
Shared decision making (SDM) is a promising avenue for
applying scientific evidence in clinical practice. SDM help
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based on two elements: the best evidence of the benefits
and harms of all available options, and patients’ values and
preferences in regard to those options, benefits, and harms
[7]. By clarifying values and improving patients’ feeling of
being adequately informed [8], SDM reduces the overuse
of screening or treatment options not clearly associated
with health benefits for all [9]. Patients’ active participation
in decision making has also been associated with favour-
able outcomes such as better quality of life [10] and higher
patient satisfaction [11-13] without increasing consultation
times [14].
SDM can be facilitated using patient decision aids.
Patient decision aids are “interventions designed to help
patients make specific and deliberative choices among
options (including the status quo) by providing (at the
minimum) information on the options and outcomes
relevant to a person’s health status and implicit methods
to clarify values,” in particular values about the benefits
and harms of the options [8]. Most patient decision aids
are designed so that patients can work through them on
their own (at home or somewhere else outside of the
consultation): for that reason, they can generally be
described as patient-mediated interventions. Only a few
have been designed for the clinician to use to facilitate
decision making at the point of care [15-17].
The present project aims to evaluate a novel tool, the
“Decision box”, which is inspired on one hand by patient
decision aids in that it also aims to improve SDM in clin-
ical practice, and on the other hand by the Drug facts
box [18] in its simple and clear format to present scienti-
fic data. Short summaries of scientific information like
the Drug facts box have been shown to help non-scien-
tists better understand the benefits and side-effects of
various types of medication [19]. In contrast to these two
types of tools, the Decision box is primarily intended for
healthcare professionals. The Decision box informs
healthcare professionals, and by extension their patients,
about the best available evidence on a large range of
healthcare interventions (see Figure 1 for an outline).
Our hypothesis is that Decision boxes will prepare clini-
cians to help their patients make informed, value-based
decisions by giving the clinicians research-based informa-
tion about the benefits and harms of various diagnostic,
therapeutic, and preventive interventions, before they
meet their patients. Decision boxes can be seen as pri-
mers that will enhance the application of evidence-based
practice and SDM during the clinical encounter.
This paper reports on the study protocol of the first
step of our research program: developing and user-test-
ing Decision boxes. More specifically, we present (1)
how we will select clinical topics for 10 Decision boxes,
(2) how we will develop the Decision boxes, (3) how we
will evaluate users’ perception of the format and content
of the Decision boxes, and (4) how we will pre-test the
questionnaires to be used in the implementation study
that will follow. This first study will provide a robust
framework for the development and testing of Decision
boxes.
Methods
Phase 1: Developing the Decision boxes
1. Selecting the clinical topics
A panel consisting of seven of the researchers involved
in this project (including four practicing family physi-
cians) will select 10 clinical topics they perceive as rele-
vant to primary care practice, including three relevant
genomic topics. They will base their selection of the
clinical topics on the following criteria:
￿ The health treatment or screening decision should
not have a single ‘best’ choice, i.e., decisions should
be considered ‘close calls’ because there is scientific
uncertainty about outcomes or because a choice
requires trading off benefits and harms [8].
￿ The clinical condition should be commonly
encountered in primary care.
￿ A strong body of clinical research on the benefits
and harms of the intervention, and ideally an apprai-
sal of the quality of the evidence, should be available
for incorporation into the Decision box.
￿ The intervention should be offered in at least one
Canadian province.
Based on a review of the literature and their clinical
experience, some of the researchers in the team (ML, FR,
RG) have already identified 10 genetic topics and 13 gen-
eral clinical, non-genetic topics that respond to these cri-
teria (Figure 2). We will propose these 23 topics to the
panellists through a web survey. Each panellist will be
asked to act independently in choosing three genetic
topics and seven non-genetic topics from those proposed.
Panellists will be asked to propose additional topics after
the first round of the survey. At this point, we will retain
the topics that were chosen by all panellists, and will
remove the topics that were chosen by three panellists or
less. We will then construct a new list of topics, consist-
ing of the topics proposed by the panellists and those
topics that were chosen by more than three but less than
all panellists (those topics that were chosen by all panel-
lists having already been retained). We will repeat this
process until a majority of panellists have selected the
same three genetic and seven non-genetic topics.
2. Developing the format and content of the prototypes
We will develop a prototype Decision box for each of the
10 topics selected. We will develop the prototypes through
an iterative process that involves (1) collaboration between
graphic designers and researchers, (2) field-testing by
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box in light of the feedback provided (Figure 3). The pro-
totypes’ design will be based on the research on risk com-
munication, as presented below. The Decision boxes will
be developed in French and in English.
I n f o r m a t i o ni n c l u d e di nt h eD e c i s i o nb o x e sEach
Decision box will begin by describing the intervention
for which a decision is required. It will then identify the
population targeted by the intervention and clarify the
decision to be considered. The box will supply research-
based information about treatment options and their
benefits, harms, probabilities, and uncertainties. It will
integrate the best evidence available from primary
research studies, systematic reviews and synopses: for
that reason, we can describe it as summary-level evi-
dence [20,21]. The box will specify the subjects studied
and the study duration. The box’s design will facilitate
comparison of the benefits and harms of each option
and will, to the extent possible, depict the benefits and
harms of each option in equal detail [22].
Risk communication formats Each Decision box will
present research-based information on the probabilities
associated with each option as a combination of numbers,
graphics and narrative statements. Although the evidence
What is a Decision box? 
x  A Decision box is a one-page summary of research-based information about the most 
important benefits and harms of a health intervention, stated simply and clearly. 
x  The Decision box informs healthcare professionals and, by extension, their patients of the 
benefits and harms of all treatment and intervention options, including the option of no 
treatment or intervention. In this way, the box prepares healthcare professionals to translate 
evidence to patients, an essential step to evidence-based practice and shared decision making. 
Who is it for? 
For healthcare professionals and, by extension, their patients 
When is it used? 
The Decision box is consulted before the encounter with the patient, as a primer that prepares 
the healthcare professional to share the information with their patients to help them make an 
informed, value-based decision. 
What does it include? 
x  The best available evidence from original research, systematic reviews and synopses 
x  Well-balanced information about the benefits and harms of all options 
x  Information about population or ‘average’ risks and a link to personalized risks and benefits 
based on individual risk factors (e.g., age, family history) when available 
x  Discussion of the limitations of results (false positives, false negatives and what is not known) 
x  A basic assessment of the quality of the evidence 
What format does it use to display risk information? 
x  A combination of numbers, graphics and narratives: 
-  Numbers as absolute risks in natural frequencies with a constant denominator across 
the benefits and harms of all options 
-  Graphics in diverse formats: part-to-whole bar graphs are preferred to convey 
conditional probabilities, ratios, and proportions 
-  Numerical information explained in words to facilitate the expression of probabilities 
Figure 1 Description of a Decision box.
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clusive [6,23], a number of reviews recommend combining
graphs with verbal and numerical formats to improve the
reader’s understanding of probabilistic information. Supple-
menting text with graphics has been proposed as a means
to reduce the influence of less-relevant textual information,
to improve decision-making and to increase accuracy when
comparing probabilities [24]. Providing multiple formats
may also help a broader audience with various numeracy
levels make more accurate assessments of risks [25].
We will express the numerical probabilities of the
benefits and harms of an intervention as absolute risk,
Genetic topics 
Antenatal screening for the detection of Down’s syndrome, Trisomy 18, and open neural tube defects  
Newborn screening for MCAD (medium chain acyl-CoA dehydrogenase) deficiency 
Screening for BRCA1 or BRCA2 gene mutations to evaluate the risk of breast and ovarian cancer 
Newborn screening for sickle cell anemia 
Screening for hereditary hemochromatosis in patients with abnormal ferritin level or abnormal transferrin 
saturation or in patients with family members with hemochromatosis 
Genotype testing for patients initiating warfarin treatment 
Screening for hypertrophic cardiomyopathy (HCM) in individuals with clinical features or a family history of 
HCM 
Testing for CDKN2A and CDK4 gene mutations to evaluate the risk of melanoma and the predisposition for 
pancreatic cancer 
Hereditary colorectal cancer screening in individuals with high risks of colorectal and endometrial cancers 
Genetic testing for factor V Leiden to identify those at an increased risk for venous thromboembolism (VTE) 
General primary care clinical  topics 
Colorectal cancer screening with faecal occult blood test 
Prostate cancer screening with the prostate-specific antigen (PSA) test 
Abdominal aortic aneurysm screening with abdominal ultrasound 
Prevention of strokes with antithrombotic therapy in patients with atrial fibrillation 
Prevention of cardiovascular events with antihypertensive drug in patients over 60 years old presenting 
essential hypertension 
Prevention of vascular diseases with acetylsalicylic acid (ASA) 
Prevention of cardiovascular diseases with statins in persons with cardiovascular risk factors 
Prevention of osteoporotic fractures with supplements (alendronate, risedronate, etidronate) in 
postmenopausal women 
Prevention of cervical cancer with the vaccine against human papillomavirus (HPV) 
Antibiotic treatment for patients with exacerbated chronic obstructive pulmonary disease (COPD) 
Treatment of Alzheimer's disease with cholinesterase inhibitors 
Intensive glycemic control in type 2 diabetes 
Treatment of mild to moderate depression with selective seratonin reuptake inhibitors (SSRIs) or St. John’s 
wort 
Figure 2 Clinical topics to be proposed to the panelists.
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denominator [5,6,26,27]. Natural frequencies facilitate
inferences on the likelihood of having a disease because
they carry implicit information about baseline risks,
reduce the number of computations required to deter-
mine the positive predictive value of a test, and cor-
respond to the way that humans have experienced
statistical information for most of the history of man-
kind [27]. Screening test results that include false posi-
tives will be segmented into pieces (prevalence, test
sensitivity, positive predictive value of a test) to improve
understanding of risk estimates [28,29].
There are two reasons why graphics are recommended
to present the probability of harm: graphics lead to
more risk aversion than numerical probability informa-
tion alone, and graphics allow the observer to process
information more effectively then when numbers are
presented on their own [29]. Research suggests that sim-
ple bar charts are preferable to more complex presenta-
tions of data [30]. Because no single graphical format
performs optimally in all situations [31], the different
Decision boxes may use different formats to display
information. We will prefer part-to-whole bar graphs to
convey conditional probabilities, ratios, and proportions,
as these graphs are believed to invoke automatic visual
area processing and proportion judgments and help
viewers attend to mathematical proportions [5].
Because the Decision boxes seek to prepare clinicians
to communicate probabilities to their patients, we will
supplement numerical and graphical information with a
short narrative statement describing the absolute risk
differences between the options available [29,32].
Similarly to the Drug facts box (Dr Lisa Schwartz, per-
sonal communication), we will reserve the bottom of
each Decision box to present confidence in the results,
using an approach adapted from the Grading of Recom-
mendations Assessment, Development and Evaluation
(GRADE) Working Group for reporting the consistency
of results, the indirectness of evidence, study limitations,
and imprecision [33].
Phase 2: User-testing the Decision boxes
1. Focus groups with users
To explore users’ perceptions of the content and format
of the Decision boxes and to seek suggestions for
improvement, we will conduct two focus groups with
family physicians and four focus groups with patients
(Figure 3). Physicians will be recruited by five members
of the research team through their professional net-
works (ML, FL, MC, PP, RG). Eligible patients will be
Decision Box 1 
(English and French) 
Decision Box 2 
(English and French) 
Presentation of the 2 boxes 
to family physicians 
Presentation of Box 1 to 
target patients (group 1) 
Presentation of Box 2 to 
target patients (group 2) 
1 focus 
group in 
English 
1 focus 
group in 
French 
1 focus 
group in 
English 
1 focus 
group in 
French 
1 focus 
group in 
English 
1 focus 
group in 
French 
Modifications / improvements of Decision Boxes 1 to 10 
Development of 10 decision box prototypes 
Selection of 2 prototypes to be tested in focus groups 
Selection of 10 clinical topics to be addressed in decision 
Figure 3 Study procedure diagram.
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port staff of the clinics of the network. Support staff will
ask them for their permission to be contacted by a
member of the research team who will then offer them
to participate in the study.
To explore physicians’ perceptions, we will present
two Decision box prototypes to a purposeful sample of
16 family physicians distributed in two focus groups: a
French-speaking group and an English-speaking group.
Each focus group will comprise eight physicians. To
explore patients’ perceptions, we will present the same
two Decision boxes to a purposeful sample of patients
from each target population (the population of patients
with the clinical condition addressed by the Decision
box). We will use a maximum variation strategy to
populate the samples [34], each of which will form a
distinct focus group. Each Decision box will thus be pre-
sented to 16 patients of the target population (eight
French-speaking and eight English-speaking patients,
distributed in a French-speaking group and an English-
speaking group), for a total of 32 patients in four focus
groups.
We will use a semi-structured interview guide to
explore users’ experience of the content and format of
the Decision boxes. The interview format will be based
on the User Experience Model by Peter Morville [35] as
used for testing the Cochrane Collaboration’s Summa-
ries of Findings table [36]. This model explores seven
facets of users’ experience (Figure 4). The interview
guide will be flexible and will cover all key topics for all
focus groups, although not necessarily in the same order
(interviews will follow the natural progression of the
conversation). The interview format will give partici-
pants the flexibility to explore emerging issues. The
interview guide used for patients will differ slightly from
that for physicians. The main objective of interviewing
the physicians is to explore the value of the tool in pre-
paring them to communicate scientific information to
patients and helping patients make informed and value-
based decisions. The objective of the interview with
patients will be to explore whether patients believe that
their physician will be better prepared to meet them
having read the box beforehand, and to ask them
whether the box contains all the information they need
to make a decision. After the focus group with patients,
they will be administered the Decisional Conflict Scale
[37], and patients with a decisional conflict measure
above 2.5 over 5 will be advised to see their doctor for
follow-up.
To enrich our understanding of the group’sv i e w s ,w e
will collect demographic data from all participants at
the beginning of each focus group. The focus groups
with physicians will last approximately two hours; those
with patients will last approximately one hour. The
focus groups will be moderated by experienced inter-
viewers (one for the French-speaking groups and one
for the English-speaking groups). Two observers (AG,
PP or ML) will take notes on the process and the con-
tent of the discussions so that participants can be identi-
fied when the interviews are transcribed [38]. One
observer (AG) will be present during every focus group
discussion, to ensure consistency of approach. Each dis-
cussion will be audiotaped and professionally tran-
scribed. Ethical approvals for this project were given by
the research ethics committees of the Centre de
Recherche du Centre Hospitalier Universitaire de Que-
bec (reference number #S10-12-114) and by McGill
University (reference number #A12-E82-10B).
2. Testing the feasibility of the questionnaire for family
physicians
Following their focus group, family physicians will
be asked to pre-test a self-administered questionnaire to
be used in a larger study on the implementation of the
Decision boxes, to take place later. Pretesting will allow
us to evaluate physicians’ understanding of the content
of the questionnaire and the feasibility of having the
useful 
accessible 
credible 
findable 
 
 
 
 
 
 
 
desirable  usable 
valuable 
Figure 4 Morville’s User Experience Honeycomb [35]. Useful: fit
for practical use in the clinical setting; Usable: the extent to which
target users can use the product to achieve specific goals with
effectiveness, efficiency and satisfaction in a given context;
Desirable: worth having and wanted by most people; Findable: the
ease with which the information sought can be found within the
product; Accessible: the degree to which the product can be
accessed by as many people as possible; Credible: worthy of belief
or trust; Valuable: able to advance the “mission” (for this study,
Decision boxes are deemed valuable if they increase the use of
evidence-based practice and increase shared decision making in
clinical practice).
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tions. The questionnaire will be made available in Eng-
lish and in French. It will collect the respondent’s
sociodemographic characteristics and will evaluate the
respondent’s interest in the clinical topic using a visual
analogue scale ranging from “no interest” to “deep inter-
est”. The questionnaire will include the information
sub-scale of the Decisional Conflict Scale [37], the Infor-
mation Assessment Method [39], and a scale based on
the Theory of Planned Behaviour to evaluate physicians’
intention to use the Decision boxes in their practice and
to share decisions equally with their patients [40].
Open-ended questions on the relevance of the questions
and respondents’ ease of understanding will be added at
the end. We will record the time needed for physicians
to complete the questionnaire.
3. Analysis
Two individuals (one research assistant and one
researcher) will independently perform a hybrid deduc-
tive/inductive thematic qualitative data analysis of each
focus group discussion using specialized software (NVivo
9) [41]. A first analysis will be performed by a research
assistant (one in French, one in English), and a second
analysis will be performed by one of the researcher (AG).
Any disagreements between the research assistants and
the researcher will be discussed until consensus is reached.
Having the same researcher perform the second analysis
for all of the sites will ensure consistency. The coding
scheme will be developed following the User Experience
Model mentioned earlier [35] by identifying what users
experienced as barriers or facilitators to the use of the
Decision boxes and using this information to help clini-
cians share decisions with their patients. The deductive
thematic analysis will apply attributes derived a priori
from the seven facets of the User Experience Model [35]:
valuable, usable, credible, useful, desirable, accessible and
findable. The inductive thematic analysis will integrate
new themes, suggested by the data, into the scheme. We
will compare the phenomena observed to emphasize a
common tangent and will work out tree structures and
matrices for the analysis. Other members of the research
team will corroborate the findings by scrutinizing the ana-
lysis and ensuring that the new themes, tree structures
and matrices are representative of the initial data analysis
and codes assigned. We will triangulate key findings by
referring to publications on the design of tools to improve
the communication of risk [23,42].
We will also perform descriptive statistical analyses of
the answers to the questionnaire. To test the feasibility
of the questionnaire, we will evaluate response rates and
the time required to complete the questionnaire. We
will also perform a descriptive analysis of respondents’
comments about the relevance of the questions and how
well they understood them.
Discussion
This study will create a framework for the production of
Decision boxes designed to facilitate decision making
about preference-sensitive health interventions. It will
produce 10 bilingual Decision boxes on common clinical
topics in primary care, and it will generate robust evi-
dence of family physicians’ and patients’ perceptions of
the content and format of Decision box prototypes. This
preliminary work is crucial to the implementation of
Decision boxes in clinical practice.
The methodology proposed here has several strengths.
First, we will ground our development of the Decision
boxes in a thorough review of the rich evidence base on
risk communication. Second, we will develop the boxes
in both of Canada’s official languages and have them
tested by English-speakers and French-speakers alike.
And third, we will have the boxes tested by both parties
to SDM during the clinical encounter: that is, by both
family physicians and patients. The limitations of our
study lie in users’ evaluation of only two of the 10 Deci-
sion boxes we will have developed, a limitation necessi-
tated by the restricted availability of funds. The authors
are confident, however, that many of the comments
gathered on the two Decision boxes-namely, comments
regarding the boxes’ format-will apply to Decision boxes
on any clinical topic.
We plan to conduct another study that evaluates the
effect of the Decision boxes on the integration of evi-
dence-based and SDM principles in practice. We
hypothesize that exposing family physicians to a theory-
based strategy [46] to implement Decision boxes will
prime the physicians to better communicate the benefits
and harms of the available options to their patients.
This communication will cause patients to become
more involved in decisions concerning their health. By
helping to implement Decision boxes in clinical practice,
the subsequent steps of this research program will
impact not only the communication of scientific data to
physicians, but also the communication between physi-
cians and patients, leading physicians to make more
judicious use of current best evidence when making
clinical decisions together with their patients.
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